|NIH Human Embryonic Stem Cell Registry|
|Research Using This Line is Eligible for NIH Funding|
Detailed information for selected cell line:
|Cell Line:||RNJ19; disease-specific mutation|
|NIH Registration Number:||0126|
|NIH Approval Number:||NIHhESC-11-0126|
|Available for Distribution:||Yes|
NIH-funded research with this line is limited to research consistent with the following language from the informed consent document: "...characterization of stem cells from embryos discarded due to genetic defects or other abnormalities and the development of new methods for transforming stem cells into other cell types."
This cell line was derived from an embryo that definitively carried the maternal mutation for congenital nephrotic syndrome; however, the status of the paternal mutation is unknown. The line could be either a compound heterozygote (positive for both the maternal and paternal mutations), or a simple heterozygote (positive for the maternal mutation and negative for the paternal mutation).
|Submitting Organization:||Reprogenetics, LLC|
|Provider Name:||Reprogenetics, LLC|
(Emails that are offensive or unrelated to stem cells will be deleted.)